IDEXX LABORATORIES INC /DE — Director's Dealing 2023

Feb 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2023-02-14

Reporting Person: Underberg Sharon E. (EVP, GC & Corp. Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-14	Common Stock	M	483	—	Acquired	3524.9949	Direct
2023-02-14	Common Stock	M	216	—	Acquired	3740.9949	Direct
2023-02-14	Common Stock	M	138	—	Acquired	3878.9949	Direct
2023-02-14	Common Stock	M	173	—	Acquired	4051.9949	Direct
2023-02-14	Common Stock	F	305	$503.65	Disposed	3746.9949	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-14	Restricted Stock Unit	$	M	483	Disposed		Common Stock (483)	Direct
2023-02-14	Restricted Stock Unit	$	M	216	Disposed		Common Stock (216)	Direct
2023-02-14	Restricted Stock Unit	$	M	138	Disposed		Common Stock (138)	Direct
2023-02-14	Restricted Stock Unit	$	M	173	Disposed		Common Stock (173)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F2: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F3: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F4: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

F5: Not applicable.